Clinical trials
Active, not recruiting Phase 1 Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 4 |
| 2020 | 7 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 43 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| AstraZeneca | 2 |
| City of Hope Medical Center | 2 |
| Exelixis | 2 |
| HiFiBiO Therapeutics | 2 |
| M.D. Anderson Cancer Center | 2 |
| Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 2 |
| Allogene Therapeutics | 1 |
| Arcus Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 43 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Melanoma | 17 |
| Squamous Cell Carcinoma of Head and Neck | 15 |
| Colorectal Neoplasms | 14 |
| Ovarian Neoplasms | 11 |
| Stomach Neoplasms | 11 |
| Triple Negative Breast Neoplasms | 10 |
| Carcinoma, Transitional Cell | 8 |
| Urinary Bladder Neoplasms | 7 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.